Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2

Author: Ma Chelsea   Armstrong April W  

Publisher: Informa Healthcare

ISSN: 1471-1753

Source: Journal of Dermatological Treatment, Vol.25, Iss.5, 2014-10, pp. : 401-408

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content